Observations placeholder
Oxycodone and Oxycontin abuse
Identifier
024022
Type of Spiritual Experience
Background
Wikipedia
Freund and Speyer of the University of Frankfurt in Germany first synthesized oxycodone from thebaine in 1916, a few years after the German pharmaceutical company Bayer had stopped the mass production of heroin due to hazardous use, harmful use, and dependence. It was hoped that a thebaine-derived drug would retain the analgesic effects of morphine and heroin with less dependence. Unfortunately, this was ultimately not found to be the case.
The first clinical use of the drug was documented in 1917, the year after it was first developed. It was first introduced to the US market in May 1939. In early 1928, Merck introduced a combination product containing scopolamine, oxycodone, and ephedrine under the German initials for the ingredients SEE, which was later renamed Scophedal (SCOpolamine ePHEDrine and eukodAL). This combination is essentially an oxycodone analogue of the morphine-based Twilight Sleep, with ephedrine added to reduce circulatory and respiratory effects.
The personal notes of Adolf Hitler's physician, Dr. Theodor Morell, indicate Hitler received repeated injections of "eukodal" (oxycodone).
In the early 1960s, the United States government classified oxycodone as a schedule II drug.
In 1996, Purdue Pharma introduced OxyContin, a controlled release formulation of oxycodone. The product has been a commercial success, and since its introduction, Purdue has earned more than $31 billion from OxyContin.
A description of the experience
On Jan, 07, 2017 48,505 people reported to have side effects when taking Oxycodone. Among them, 2,394 people (4.94%) have Hallucinogen Abuse